293 results on '"Merchant, Nipun"'
Search Results
2. A neuroendocrine biomarker revolution from monoanalyte to multianalyte biomarkers in non-functioning gastro-entero-pancreatic neuroendocrine neoplasms
3. Utility of tumor-informed circulating tumor DNA for detection of minimal residual disease after curative-intent therapy in localized pancreatic cancer
4. Malignant Solid Pseudopapillary Neoplasm of the Pancreas: An Orthogonal Analysis
5. ZIP Code to Genomic Code: Neighborhood Disadvantage, Aggressive Breast Cancer Biology, and Breast Cancer Outcomes
6. Racial Disparity in Pathologic Response following Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: A Multi-Institutional Analysis from the Central Pancreatic Consortium
7. Translational Epidemiology: Genetic Ancestry in Breast Cancer: What Is the Role of Genetic Ancestry and Socioeconomic Status in Triple-Negative Breast Cancer?
8. Intraoperative Pancreatic Neck Margin Assessment During Pancreaticoduodenectomy for Pancreatic Adenocarcinoma in the Era of Neoadjuvant Therapy: A Multi-institutional Analysis from the Central Pancreatic Consortium
9. Combined MEK and STAT3 Inhibition Uncovers Stromal Plasticity by Enriching for Cancer-Associated Fibroblasts With Mesenchymal Stem Cell-Like Features to Overcome Immunotherapy Resistance in Pancreatic Cancer
10. Prescription patterns of pancreatic enzyme replacement therapy for patients with pancreatic cancer in the United States
11. Distinct mechanisms of innate and adaptive immune regulation underlie poor oncologic outcomes associated with KRAS-TP53 co-alteration in pancreatic cancer
12. Standardization of EUS imaging and reporting in high-risk individuals of pancreatic adenocarcinoma: consensus statement of the Pancreatic Cancer Early Detection Consortium
13. Landmark Series: Importance of Pancreatic Resection Margins
14. Interleukin-1 signaling in solid organ malignancies
15. Survival inequity in vulnerable populations with early-stage hepatocellular carcinoma: a United States safety-net collaborative analysis
16. An Immunocompetent Model of Pancreatic Cancer Resection and Recurrence
17. National Institutes of Health Research Funding to Academic Surgical Oncologists: Who Are We and Where Do We Stand?
18. Multiomic Characterization Reveals a Distinct Molecular Landscape in Young-Onset Pancreatic Cancer
19. Overcoming disparities: Multidisciplinary breast cancer care at a public safety net hospital
20. CTNNB1 exon 3 mutations in metastatic solid pseudopapillary neoplasm of the pancreas.
21. Lymph node metrics following neoadjuvant therapy to refine patient selection for adjuvant chemotherapy in resected pancreatic cancer: A multi‐institutional analysis.
22. Neoadjuvant Therapy: When Should It Be Used for Pancreatic Cancer?
23. Disparities in Presentation at Time of Hepatocellular Carcinoma Diagnosis: A United States Safety-Net Collaborative Study
24. Minimally Invasive Surgery is Associated with an Increased Risk of Postoperative Venous Thromboembolism After Distal Pancreatectomy
25. Utility of Radiation After Neoadjuvant Chemotherapy for Surgically Resectable Esophageal Cancer
26. Increased MTH1-specific 8-oxodGTPase activity is a hallmark of cancer in colon, lung and pancreatic tissue
27. Radiation Therapy for Pancreatic Cancer: Executive Summary of an ASTRO Clinical Practice Guideline
28. Cyst location and presence of high grade dysplasia or invasive cancer in intraductal papillary mucinous neoplasms of the pancreas: a seven institution study from the central pancreas consortium
29. Neighborhood Disadvantage, Aggressive Breast Cancer Biology, and Breast Cancer Outcomes.
30. National Institutes of Health Career Development (K) Awards to Young Surgeons: An Academic Milestone or One-hit Wonder?
31. The Role of Surgical Resection for Stage IV Gastric Cancer With Synchronous Hepatic Metastasis
32. NFκB in Pancreatic Stellate Cells Reduces Infiltration of Tumors by Cytotoxic T Cells and Killing of Cancer Cells, via Up-regulation of CXCL12
33. Fine-needle aspiration–based grading of pancreatic neuroendocrine neoplasms using Ki-67: is accurate WHO grading possible on cytologic material?
34. An academic career in global surgery: a position paper from the Society of University Surgeons Committee on Academic Global Surgery
35. Perioperative Gemcitabine + Erlotinib Plus Pancreaticoduodenectomy for Resectable Pancreatic Adenocarcinoma: ACOSOG Z5041 (Alliance) Phase II Trial
36. The Impact of Surgeon Volume on Outcomes After Pancreaticoduodenectomy: a Meta-analysis
37. Pancreatic Neuroendocrine Tumors (panNETs): Analysis of Overall Survival of Nonsurgical Management Versus Surgical Resection
38. Are the Current Guidelines for the Surgical Management of Intraductal Papillary Mucinous Neoplasms of the Pancreas Adequate? A Multi-Institutional Study
39. Distal Cholangiocarcinoma and Pancreas Adenocarcinoma: Are They Really the Same Disease? A 13-Institution Study from the US Extrahepatic Biliary Malignancy Consortium and the Central Pancreas Consortium
40. Stroma secreted IL6 selects for “stem-like” population and alters pancreatic tumor microenvironment by reprogramming metabolic pathways
41. A Novel Interdisciplinary Iterative Approach for Optimizing the Electronic Health Record to Improve Perioperative Efficiency
42. Patterns of National Institutes of Health Grant Funding to Surgical Research and Scholarly Productivity in the United States
43. Commentary on “Patient-derived Organoid Pharmacotyping is a Clinically Tractable Strategy for Precision Medicine in Pancreatic Cancer”
44. Dual Src and EGFR inhibition in combination with gemcitabine in advanced pancreatic cancer: phase I results: A phase I clinical trial
45. Delayed gastric emptying after pancreaticoduodenectomy
46. Perception Is Reality: quality metrics in pancreas surgery – a Central Pancreas Consortium (CPC) analysis of 1399 patients
47. Phase I trial of vorinostat added to chemoradiation with capecitabine in pancreatic cancer
48. Adjuvant Therapy in Pancreas Cancer: Does It Influence Patterns of Recurrence?
49. Advances in the Surgical Management of Resectable and Borderline Resectable Pancreas Cancer
50. The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.